Trial Profile
A Double Blind, Double Dummy, Randomized, Two Way Cross-over Study to Compare the Effects of Z7200 and Symbicort Turbohaler on Functional Respiratory Imaging Parameters in Asthmatic Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Jan 2022
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Zambon SpA
- 16 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Oct 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Sep 2014 New trial record